Page last updated: 2024-09-04

2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a and azomycin

2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a has been researched along with azomycin in 1 studies

Compound Research Comparison

Studies
(2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a)
Trials
(2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a)
Recent Studies (post-2010)
(2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a)
Studies
(azomycin)
Trials
(azomycin)
Recent Studies (post-2010) (azomycin)
695394,7904181,580

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Busch, TM; Cheney, RT; Gollnick, SO; Henderson, BW; Kousis, PC; Morgan, J; Snyder, JW1

Other Studies

1 other study(ies) available for 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a and azomycin

ArticleYear
Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors.
    Cancer research, 2004, Mar-15, Volume: 64, Issue:6

    Topics: Animals; Apoptosis; Caspase 3; Caspases; Chemokine CCL4; Chlorophyll; Colonic Neoplasms; Endothelium; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; In Situ Nick-End Labeling; Interleukin-6; Macrophage Inflammatory Proteins; Mice; Mice, Inbred BALB C; Neutrophils; Nitroimidazoles; Oxygen; Photochemotherapy; Photosensitizing Agents

2004